CC-90003
CC-90003 is an irreversible and selective inhibitor of ERK 1/2 with antitumor activity.
Product Specifications
CAS Number
[1621999-82-3]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
ERK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/CC-90003.html
Purity
99.71
Solubility
DMSO : ≥ 125 mg/mL
Smiles
C=CC(NC1=CC(C)=CC=C1NC2=NC(NC3=CC(OC)=NC=C3C)=NC=C2C(F)(F)F)=O
Molecular Formula
C22H21F3N6O2
Molecular Weight
458.44
Precautions
H302, H315, H319, H335
References & Citations
[1]Monica M. Mita, et al. A phase Ia study of CC-90003, a selective extracellular signal-regulated kinase (ERK) inhibitor, in patients with relapsed or refractory BRAF or RAS-mutant tumors. Journal of Clinical Oncology 35, no. 15_suppl (May 20 2017) 2577-2577.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
ERK1; ERK2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6451334-01 0.1 mL
PDCD1LG2 (Programmed Cell Death 1 Ligand 2, B7DC, Btdc, CD273, MGC142238, MGC142240, PD-L2, PDCD1L2, PDL2, bA574F11.2) (APC)
Ask
View Details 
MBS6451334-02 5x 0.1 mL
PDCD1LG2 (Programmed Cell Death 1 Ligand 2, B7DC, Btdc, CD273, MGC142238, MGC142240, PD-L2, PDCD1L2, PDL2, bA574F11.2) (APC)
Ask
View Details 
bsm-33187M-PE-Cy5.5 100 µL
Alpha smooth muscle Actin Monoclonal Antibody, PE-Cy5.5 Conjugated
Ask
View Details